SVCM
Saturn V Capital Management Portfolio holdings
AUM
$247M
1-Year Return
2.68%
This Quarter Return
-8.04%
1 Year Return
+2.68%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$255M
AUM Growth
-$24.4M
(-8.7%)
Cap. Flow
+$9.39M
Cap. Flow
% of AUM
3.68%
Top 10 Holdings %
Top 10 Hldgs %
71.55%
Holding
30
New
5
Increased
10
Reduced
8
Closed
6
Top Buys
| 1 |
Xenon Pharmaceuticals
XENE
|
$12.6M |
| 2 |
CTNM
Contineum Therapeutics
CTNM
|
$7.26M |
| 3 |
Syndax Pharmaceuticals
SNDX
|
$6.43M |
| 4 |
Merus
MRUS
|
$4.35M |
| 5 |
Amylyx Pharmaceuticals
AMLX
|
$3.36M |
Top Sells
| 1 |
Phathom Pharmaceuticals
PHAT
|
$15.8M |
| 2 |
Neumora Therapeutics
NMRA
|
$5.72M |
| 3 |
BioMarin Pharmaceuticals
BMRN
|
$2.63M |
| 4 |
Crinetics Pharmaceuticals
CRNX
|
$2.58M |
| 5 |
ITOS
iTeos Therapeutics
ITOS
|
$2M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
ArriVent BioPharma
AVBP
$792M
| – | – |
-47,266
| Closed | -$1.11M |
|
|
LBPH
27
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
| – | – |
-31,529
| Closed | -$1.05M |
|
|
28
BioMarin Pharmaceuticals
BMRN
$10.9B
| – | – |
-37,432
| Closed | -$2.63M |
|
|
ITOS
29
DELISTED
iTeos Therapeutics
ITOS
| – | – |
-195,704
| Closed | -$2M |
|
|
30
Neumora Therapeutics
NMRA
$264M
| – | – |
-432,996
| Closed | -$5.72M |
|